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Abstract
Background: Ventricular septal defect (VSD) is a highly prevalent fetal congenital heart defect, which can become
spontaneously closed during infancy. The current study aims to characterize fetal VSDs that were subsequently
spontaneously closed in the first 2 years of life in eastern China.
Methods: Between January 2011 and December 2013, 257 fetal patients diagnosed with isolated VSD by fetal
echocardiography at Nanjing Maternity and Child Health Care Hospital, China, were enrolled in the study. Subjects
were divided into three groups: group 1 = persistent VSD; group 2 = closed after birth; group 3 = closed during
gestation. Fetal echocardiography data, physical features at birth and follow-up outcomes for 2 years were
compared to identify factors contributing to spontaneous closure (SC) of VSD. A predictive formula was applied to
patients admitted to hospital in the first quarter of 2014 (n = 23) for validation.
Results: SC occurred in 42.8% patients. Birth weight (3.095 ± 0.774, 3.174 ± 0.535, 3.499 ± 0.532 kg in groups 1, 2
and 3, respectively) and defect diameter (3.422 ± 0.972, 2.426 ± 0.599, 2.292 ± 0.479 mm, in groups 1, 2 and 3,
respectively) showed statistically significant differences between the three groups (P = 0.004 and P = 0.000,
respectively). Receiver operating characteristic (ROC) curves identified cut-off value for the defect diameter as 2.
55 mm, and logistic regression analysis identified the SC probability = (1 + exp -[-2.151 − 0.716*birth weight + 1.
393*diameter])-1. Results indicated that male fetuses, full-term birth, muscular VSD, and defects without blood flow
crossing the septum, have higher incidence of SC.
Conclusions: The major determinants of SC of isolated VSD are birth weight and diameter of the defect. In
addition, VSD location may also affect the SC incidence.
Keywords: Ventricular septal defects, Spontaneous closure, Fetal echocardiography
Background
The incidence of congenital heart disease (CHD) in the
western world is 0.3–1.2% of live births [1]. Ventricular
septal defect (VSD) is the most common congenital heart
defect, accounting for 20–30% of all congenital heart
defects [2]. In a recent study, Zhao et al. [3] described a
2.66% prevalence of CHD at live birth in China using
echocardiographic screening, and they also found that
only a 1.21% prevalence of CHD that could be detected by
clinical evaluation, with the most common CHD as VSD
at a prevalence of 1.73%. VSDs can occur alone or in com-
bination with other cardiac defects. However, the majority
of VSDs occur alone and referred to as “isolated” or “sim-
ple” [4], and the current study has therefore focused on
isolated VSDs. VSDs are typically asymptomatic and often
close spontaneously [5]. Two-dimensional echocardiog-
raphy combined with pulsed Doppler or Doppler color
flow mapping is a well-established technique to diagnose
and localize fetal and infant VSDs. The present study
utilized fetal echocardiography and state at birth to evalu-
ate the incidence and timing of SC of VSD in patients
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who were diagnosed with VSD prenatally in eastern China.
There have been a number of observational long-term
follow-up studies on spontaneous closure (SC) of VSD
[6–29], but few of these reports were followed up from
the fetal period. Here, we present a long-term follow-up
study in which subjects were followed up from the fetal
period and summarized a prediction formula including
factors influencing SC of VSD. We found that birth weight
was a prognostic variable for SC of VSD, which was most
useful for pediatricians, and that the defect diameter was
another prognostic variable, which may provide useful in-




A total of 5855 pregnant women underwent fetal echocar-
diography examination between January 2011 to December
2013 at the Fetal Echocardiography Department of Nanjing
Maternity and Child Health Care Hospital, Nanjing, China.
Of these women, 1168 cases had cardiac structural abnor-
malities, and 335 fetal patients diagnosed with isolated VSD
were enrolled in current study.
Indications for fetal echocardiography
Pregnant women in the following status during their rou-
tine obstetric examination were recommended a further
fetal echocardiography examination: suspected CHD on
screening ultrasound during the second trimester; extra-
cardiac anomalies on screening ultrasound; advanced ma-
ternal age; family history of CHD; increased nuchal
translucency; fetal arrhythmia; chromosomal abnormality.
Diagnostic criteria of VSD by echocardiography
Two skilled sonographers (Li Cao and Yun Wu) con-
ducted all the fetal echocardiography examinations using
the Acuson Sequoia 512 ultrasound system (Siemens,
Malvern, PA, USA) with a 3 − 5-MHz phased-array trans-
ducer. Complete transthoracic two-dimensional, M-mode,
continuous wave and pulsed wave Doppler and color Dop-
pler echocardiographic examinations were performed. An
echo dropout in the ventricular septum in two-
dimensional echocardiography was considered diagnostic
of a VSD (Figs. 1 and 2). A typical systolic colored flame
(Figs. 3 and 4) crossing the septum and in most cases a jet
derived from pulsed Doppler confirmed the existence of
the defect (however, if the shunt blood pressure is low,
colored jet crossing the septum may not be detected). Ex-
treme care was taken to determine location and width of
defects. The diameter of VSD in two-dimensional and/or
color flow mapping was measured in all planes and the
largest diameter of VSD was recorded. Apical four-
chamber, apical five-chamber, parasternal long- and short-
axis and subcostal positions were used to image the defect,
with a minimum of no less than three views. Defects were
classified as perimembranous, muscular, subarterial or
multiple types (more than one defect) [30]. Infants who
had associated complex structural cardiovascular defects
were excluded from the isolated VSD group.
Follow-up studies
Parental consents were obtained from the parents of
each neonate. Detailed history of the neonates, parents
and family members were taken by face-to-face or tele-
phone interviewing of the parents. A fetal echocardiog-
raphy reexamination in third trimester and repeated
echocardiographies at the children’s routine physical ex-
aminations at age 1, 3, 6 and 12 months of age depend-
ing on the growth and development condition of the
Fig. 1 White arrow indicates a small VSD detected by fetal
echocardiography, and SC during follow-up
Fig. 2 White arrow indicates a large VSD detected by fetal
echocardiography, and no SC during follow-up
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children until the spontaneous or surgical closure of the
VSD was confirmed, were recommended to all parents.
Spontaneous closure occurred in patients without echo
dropout in the septum and without detection of blood
flow through the septum in echocardiography.
Data in the ultrasound records consisted of gestational
weeks, maternal age, fetal heart rate, width of aorta and
pulmonary artery, location and diameter of the defect, dir-
ection of the shunt. Questions in the interview included:
(1) Did the defects close or not? (2) When did the spon-
taneous closure occur? (3) What treatments are used for
those whose defects persist? (4) Gender and birth weight
of the infancy. (5)Was there premature delivery? (6) Were
there any infections or metabolic diseases during preg-
nancy? (7) Is there any family history of heart disease?
Besides, fetal karyotype examination results of those who
received amniocentesis were also collected.
Validation study of the prediction formula
In the second part of the study, the prediction formula
was then applied to 23 patients, who were admitted to
the hospital in the first quarter of 2014 in order to valid-
ate the derived prediction formula.
Statistical analysis
All data are expressed as mean ± standard deviation
(SD). The differences among the three groups were
assessed using analysis of variance (ANOVA) for con-
tinuous variables, and student-neuman-keuls tests were
applied for post-hoc comparisons. Comparisons between
group 1, 2 and 3 were made using Chi-square tests for
categorical variables. A P-value <0.05 was considered
statistically significant. Statistically significant clinical
and echocardiographic variables were subsequently eval-
uated by binary logistic regression analysis to identify in-
dependent predictors of outcome. Receiver operating
characteristic (ROC) analysis was performed to assess
the sensitivity and specificity of the diameter of the de-
fect for predicting SC of VSD.
Results
A total of 335 fetal patients, referred for fetal echocar-
diographic examination and diagnosed with isolated
VSD at Nanjing Maternity and Child Health Care Hos-
pital between January 2011 and December 2013, were
enrolled in this retrospective study. In spite of repeated
efforts to contact the parents, 78 patients were lost to
follow-up after the initial first or second visit. Follow-up
was completed in 257 (76.7%) patients. Outcomes for
these patients are summarized in Fig. 5. According to
whether the defect in ventricular septum was closed or
not, children were divided into three groups: groups 1 =
defects not yet closed (this group included infants who
died after birth because of VSD, and who underwent
surgical intervention, and whose defects persisted by the
time of follow up); group 2 = defects closed after birth;
group 3 = defects were closed during gestation.
General conditions
Mean gestational age was 26.68 ± 1.092 weeks (range,
19–30 weeks) at the time when the fetuses were diag-
nosed with VSD. The average maternal age of the study
population was 29.25 ± 4.874 years (range, 20 − 42 years).
Sex ratio for the patients was 82 males: 69 females.
Percentages of different types of defects were as follows:
perimembranous, 115 (78.8%); muscular, 20 (13.7%);
subarterial, 7 (4.8%); multiple, 4 (2.7%). The average time
when spontaneous closure occurred was 7.31 ±
6.073 months.
Fig. 3 Color Doppler echocardiographic examination of small VSD
Fig. 4 Color Doppler echocardiographic examination of large VSD
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Clinical findings
The birth weights and diameter of the defects between
the three groups were significant different (P = 0.004 and
P = 0.000, respectively), with the highest birth weights
observed in patients whose defects closed within gesta-
tion and the largest diameter of the defectsin patients
whose defects persisted (Table 1). The proportion of pre-
term birth was lower in group 3 (P = 0.058; Table 2).
Furthermore, gender differences were noted between the
groups, whereby male predominance was observed in
group 3 (SC during gestation) and female predominance
in group 1 (defects not closed), although these differ-
ences did not reach statistical significance (Table 2). SC
rates at different locations are also detailed in Table 2.
All the muscular defects have been closed, higher than
rate of spontaneous closure (81.8–89% at 12-month
follow-up) of muscular VSD was reported in previous
studies. There were 11 cases without detection of blood
flow through the septum that experienced spontaneous
closure.
ROC curve
When SC is defined as a state variable and the defect diam-
eter is defined as a test variable, the value of state variable
set to zero, a receiver operating characteristic curve can be
achieved. Area under the curve is 0.842, P = 0.000. Cut-off
value is 2.55 mm. In this case, sensitivity = 0.800, specifi-
city = 0.718 (Fig. 6).
Logistic regression analysis
To estimate the SC probability for a given defect diam-
eter and birth weight, logistic regression analysis was
used. After removing the impact of the defect location,
birth weight was identified a protective factor [odds ratio
(OR) value: 0.498; 95% CI 0.244, 0.978] while defect
diameter was identified as a risk factor [OR value:
4.072; 95% CI: 1.885, 8.604] for SC. The relationship
between defect diameter plus birth weight and SC
probability was described by the following prediction
formula: probability = (1 + exp -[-2.151-0.716*birth
weight +1.393*diameter]) -1.
Fig. 5 Study flow chart for the outcome of fetuses with VSD after birth
Table 1 Statistical results of quantitative data are shown in Table 1
Group 1 Group 2 Group 3 P value
Birth weight M ± SD 3.095 ± 0.774 3.174 ± 0.535 3.499 ± 0.532 0.004*
95% CI (2.851,3.339) (3.035,3.313) (3.155,3.359)
Diameter M ± SD 3.422 ± 0.972 2.426 ± 0.599 2.292 ± 0.479 0.000*
95%CI (3.146,3.698) (2.273,2.579) (2.154,2.429)
Maternal age M ± SD 29.10 ± 4.610 28.43 ± 5.393 30.45 ± 4.282 0.245
Aortic diameter M ± SD 4.62 ± 0.585 4.74 ± 0.529 4.76 ± 0.437 0.193
Pulmonary artery diameter M ± SD 5.52 ± 0.542 5.66 ± 0.561 5.60 ± 0.481 0.469
Fetal heart rate M ± SD 145.65 ± 8.089 146.53 ± 6.427 146.92 ± 7.957 0.177
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Verification of the prediction formula
Follow-up outcome was compared with the probability
calculated by our prediction formula, and 82.6% (19/23)
of the predicted results coincided with the actual out-
comes (Tables 3 and 4). We used these data to draw a 3
dimensional scatterplot, diameter of the defect is X axis,
P value is Y axis and birth weight is Z axis. As we can
see, with lager defect diameter and lower birth weight
come with higher P value, which means the defects are
more likely to stay persistent (Fig. 7).
Fetal karyotype of VSDs
Karyotyping was performed in 80 cases: 71 (88.75%) fe-
tuses had a normal karyotype, and 9 (11.25%) cases of
chromosomal anomalies were identified. Among the cases
with aneuploidy, there were 7 cases with trisomy 18, 1
case with Turner syndrome, and 1 case with balanced
translocations. Seven of 9 fetuses with trisomy 18 pre-
sented with a perimembranous VSD, 1 case with a mixed-
type VSD and 1 case had a muscular defect (Table 5).
Discussion
The present study was conducted in order to evaluate
SC rate of isolated VSD and the clinical characteristics
and prognosis of VSD patients from fetal age until
2 years after birth, in eastern China. While the incidence
of VSD has increased in recent years, there has been ad-
vancement of fetal echocardiographic technology, allow-
ing more accurate diagnosis of fetal congenital heart
defects [31, 32]. Fetal heart examination is possible by
transvaginal transducers as early as 9 − 10 weeks of ges-
tation, and good quality transabdominal echo pictures
are generally obtainable by 16 gestational weeks. In the
current study, patients were evaluated during in second
and early third trimester of pregnancy. Fetal cardiac
Table 2 Statistical results of qualitative data are shown in Table 2
Group 1 Group 2 Group3 P value
n(%) n(%) n(%)
Delivery Premature 10/23 (43.5%) 10/23 (43.5%) 3/23 (13.0%) 0.058
Mature 32/127 (25.2%) 51/127 (40.2%) 44/127 (34.6%)
Gender Male 18/82 (22.0%) 33/82 (40.2%) 31/82 (37.8%) 0.119
Female 24/69 (34.8%) 28/69 (40.6%) 17/69 (24.6%)
Location Perimembranous 34/115 (29.6%) 46/115 (40.0%) 35/115 (30.4%) 0.007*
Muscular 0/20 (0%) 11/20 (55.0%) 9/20 (45.0%)
Subpulmonary 2/3 (66.7%) 0 (0%) 1/3 (33.3%)
Multiple 2/4 (50.0%) 1/4 (25%) 1/4 (25%)
Shunt direction Left-to-right 39/105 (37.1%) 30/105 (28.6%) 36/105 (34.3%) 0.011*
Right-to-left 4/14 (28.6%) 7/14 (50%) 3/14 (21.4%)
Bilateral 6/28 (21.4%) 17/28 (60.7%) 5/28 (17.9%)
Not detected 0 (0%) 7/11 (63.6%) 4/11 (36.4%)
Maternal disease No signs of disease 39/129 (30.2%) 50/129 (38.8%) 40/129 (31.0%) 0.350
Influenza 5/13 (38.5%) 6/13 (46.2%) 2/13 (15.4%)
Hyperglycemia 6/14 (42.9%) 3/14 (21.4%) 5/14 (35.7%)
Hypertension 1/3 (33.3%) 0 2/3 (66.7%)
Hyperthyreosis 0/1 (0%) 1/1 (100%) 0/1 (0%)
Fig. 6 When SC is defined as a state variable and the defect
diameter is defined as a test variable, the value of state variable is
set to zero, and a receiver operating characteristic (ROC) curve can
be achieved. Area under the curve is 0.842; P = 0.000; Upper
cut-off value = 2.55 mm
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screening is typically carried out at 18 − 22 gestational
weeks, since fetal cardiac anatomical details, including
ventriculoarterial connections, are possible to evaluate at
this stage [33]. Subjects included in the present study
were all in line with the indications for fetal echocardi-
ography, ensuring efficient detection of CHD. Common
referral indications include abnormal cardiac screening
ultrasound, extracardiac anomalies shown on screening
ultrasound, maternal diabetes, and family history of
CHD [34].
In 1918, a French study reported the clinical findings
in a young boy whose murmur and thrill disappeared at
5 years of age, documenting from first record of SC of
VSD [35]. Here, we have reviewed reports on SC of VSD
1987 to 2015 from various countries, which have been
detailed in Table 6. Reported closure rates vary from 6
to 88.9% with size and location of VSD, age at presenta-
tion and patient population, and results from our study
are consistent with previous reports [6, 8, 9, 18]. SC of
VSD is most common during the first year of life, with
the likelihood of SC decreasing during adolescent years
and adult life. It has been reported that the SC rate of
patients with VSD not receiving surgical closure during
childhood was as low as 6% [17].
In line with many previous reports, perimembranous VSD
was the most prevalent form of VSD, and muscular VSD
had an obviously higher SC rate [8, 10–12, 15, 18, 20, 22].
However, the average diameter of muscular VSD was
Table 3 Verification: List of children whose defects spontaneously closed
ID Predicted probability Actual outcome Time of SC Birth weight (kg) Defect diameter (mm)
01 0.2873 Closed In gestation 3.1 2.7
02 0.3669 Closed In gestation 3.4 2.9
03 0.1889 Closed 6 months 3.7 2.4
04 0.3133 Closed 3 months 3.15 2.6
05 0.1926 Closed In gestation 4.25 2.7
06 0.1113 Closed Neonatal 3.4 1.8
07 0.1454 Closed 3 months 3.75 2.2
08 0.2818 Closed Neonatal 3.75 2.8
09 0.1033 Closed Neonatal 4.1 2.1
10 0.2598 Closed In gestation 4.1 2.9
11 0.5068 Closed 6 months 2.6 2.9
12 0.4700 Closed In gestation 3 3
13 0.0619 Closed In gestation 4.1 1.7
14 0.3049 Closed 6 month 3.4 2.7
15 0.1883 Closed 12 month 3.9 2.5
SC spontaneous closure
In the binary logistic regression, spontaneous closure is defined as 0, persisted defect is defined as 1, and predicted probability stands for the possibility of
persisted defects
The predicted possibilities of the patients whose defects closed spontaneously are all below 0.5 (except for patent No.11)
Table 4 Verification: List of children whose defects didn’t spontaneously close
ID Predicted probability Actual outcome Birth weight(kg) Defect diameter(mm) Note
01 0.8469 Thoracotomy surgery 2 3.8
02 0.6264 Mortality 2.5 3.2 Respiratory failure
03 0.3467 Mortality 2.55 2.4 Down’s syndrome
04 0.4700 Defect reduced 3 3
05 0.5496 Defect persisted 4.5 4
06 0.7362 Defect persisted 3.15 3.9
07 0.4056 Defect reduced 3.95 3.3
08 0.7984 Defect persisted 3.05 4.1
In the binary logistic regression, spontaneous closure is defined as 0, persisted defect is defined as 1, and predicted probability stands for the possibility of
persisted defects
Patients with predicted possibility above 0.5 experienced surgery (No.01), mortality (No.02), or persistent defects (No.05,06.08), while patients with predicted
possibility below 0.5 had reduced defects (No.04,07). Patient No.03 has Down’s syndrome
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smaller than other types and none of the subjects required
surgical intervention. The closure of muscular defects begins
with septal muscle adherence, followed by obliteration of
the defect by a fibrous tissue plug [36, 37]. In closure of
membranous defects, the VSD is “covered” by tricuspid
valve tissue [38, 39], Nir [39] also suggested that closure of
membranous VSDs may begin in utero and the mechanism
of closure was similar to that of postnatally.
The postnatal closure of the muscular septum has
been hypothesized that ventricular septal closure may
not be limited to the fourth and fifth postconceptive
weeks, and may extend throughout pregnancy and into
the postpartum period. In many cases, these muscular
VSD may result from a delayed normal process rather
than from disease [11]. Therefore, to avoid unnecessary
anxiety, parents should be informed of this benign mus-
cular ventricular septal defect whether it is identified by
echocardiography intentionally or accidentally.
The incidence of subaterial VSD in the present study was
comparable to the incidence in the West [6, 20, 29], but
much lower than that reported in Japan [18]. Although this
type of VSD seldom closed spontaneously, SC patients in
our study had no prolapse of the aortic valve at the time of
SC. We therefore postulate that SC probably occurred by
growth of muscular septum surrounding VSD. Previous
studies have reported higher SC rates in smaller compared
to larger defects [13, 16, 26]. In our research, Group 3
whose defects closed during gestation has the lowest aver-
age defect diameter, indicating that smaller defects are
associated with better the prognosis, with a defect diameter
cut-off value determined at 2.55 mm, when the SC occurs.
Subjects with SC during gestation had the highest
average birth weight, with relatively better outcomes,
probably due to better blood circulation and nutrient
status. Birth weight is affected by maternal and fetal
genotype as well as environmental factors, and placental
function is also an important factor. Levin [40] and Levy
[41] reported that low birth weight infant and intrauter-
ine growth retardation(IUGR) were more common in
children with cardiovascular malformations. Levy [41]
also pointed out that a hemodynamic change may ex-
plain lower birth weight by alterations of the fetal circu-
lation. Low birth weight and prematurity and are known
risks for mortality during surgery for CHD [42]. Lesions
causing left to right shunt, pulmonary outflow tract ob-
struction or left ventricular outflow tract obstruction
can severely affect intrauterine growth, resulting in small
for gestational age fetuses [43]. Wei et al. [44] reported
that a weight over 2.4 kg at the time of cardiovascular
surgery was associated with lower rates of postoperative
infections. Fisher et al. [45] concluded that infants with
serious congenital heart disease (CHD) appear to be at
increased risk for necrotizing enterocolitis (NEC). The
incidence of NEC is significantly higher in very low birth
weight neonates when CHD is present. We hypothesized
that children with higher birth weight have a better
hemodynamic and nutritional status as well as a stronger
Fig. 7 A three dimensional scatterplot was drawn by SPSS, diameter
of the defect is X axis, P value is Y axis and birth weight is Z axis. As
we can see, with lager defect diameter and lower birth weight
come with higher P value, which means the defects are more likely
to stay persistent
Table 5 Fetal karyotype of the VSD
Karyotype Gestational weeks(w) Maternal ages(y) Location Defect diameter Outcome
47, XY, +18 26 26 Membranous 4.8 mm TOP
46, XX, t(10;13)(p13;q14) 25 24 Membranous 1.6 mm Closed
47, XX, +18 24 32 Mixed type 7 mm TOP
45, X 26 28 Muscular 3 mm TOP
47, XX, +18 24 32 Membranous 5.3 mm TOP
47, XX, +18 23 43 Membranous 3.5 mm TOP
47, XX, +18 22 30 Membranous 3.9 mm TOP
47, XX, +18 22 25 Membranous 4.4 mm TOP
47, XY, +18 26 29 Membranous 6.1 mm TOP
TOP termination of pregnancy, w weeks, y years old
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Table 6 Single studies on spontaneous closure of ventricular septal defect
First Author Place(Years) Number Starting point Follow up Classification Classification of VSD Spontaneous closure
No.(%)
Influencing Factor
Moe [6] Washington, USA
(1987)












169 <4 w 29 m perimembraneous 35 (20.1%), muscular125 (71.8%),
malalignment 12 (6.9%), subpulmonary 2 (1.1%)
70 (42.6%) location









125 2.4 m 32 m Muscular VSD midmuscular 55 (44%), apical 31 (25%), anterior 33
(26%), and posterior 6 (5%)
30 (31%)
Roguin [11], Nahariya, Israel
(1995)
56 6–170 h 10 m Muscular VSD 40 (88.9%) a delayed normal process
Du [12], Nahariya, Israel
(1996)
9/159 2–120 h 10 m Muscular VSD
preterm neonate
8 (87.5%)
Shirali [13], Texas,USA (1995) 149 <6 m 28 m periembranous 100 (68.9%) muscular 49 (33.7%)
canal-type 5 (3.4%) conal-septal 2 (1.8%)
46 (31%) size and location
Krovetz [14] Florida,USA (1997) 692 7 h–23y 3 ~ 18y 490 (70.8%)
Turner [15] Newcastle,UK
(1999)
68 2d–42 m 76 m small 49, moderate 14, large 5. 35.0% location
Paladini [16] Naples,Italy (2000) 68 24.8w 1y Isolated VSD Perimembranous inlet 22 (32.4%),outlet 19 (27.9%);
muscular 7 (10.3%), malalignment 16 (23.5%)
In utero: 46.1%,
postnatal : 23.1% not
close: 30%
size and location
Gabriel [17], Vienna, Austria
(2002)
222 20.8y 7.4y perimembranous 194 (84.8%), trabecular 30 (13.1%),




225 30d ~ 3 m 6y perimembranous159 (70%) muscular 35 (16%)
subpulmonary 31 (14%),
107 (48%) location
Atalay [19] Ankara, Turkey
(2005)
42 <6 m 2 ~ 10y Small Apical
Muscular VSD





146 23.4w 1y Isolated VSD perimembranous 15 (10.3%) muscular 131 (89.7%):





Abbag [39] Saudi Arabia
(2006)
86 14 m 66.3 m perimembranous 67.4%, muscular 19.8%, inlet 7%
subarterial 5.8%.
16.30% age, size
Atik [21] São Paulo Brazil
(2008)
155 8d 1–18Y Small VSD perimembranous 68 (36.3%) muscular 119 (63.6%) 48 (75%) location
Miyake [22], Osaka, Japan
(2008)
48 2y 17.8y Perimembranous
VSD










Table 6 Single studies on spontaneous closure of ventricular septal defect (Continued)
Chang [23] Kaohsiung,
Taiwan (2010)
66 1y MuscularVSD midmuscular 37, apical 24, anterior 5 54 (81.8%)
Jin [24] Shandong, China
(2012)
96 24 ~ 40w 3y Perimembranous 14,
Muscular 52
in utero: 3%, postnatal:
83.3% not close: 3.9%
size and location
Sun [25] Shanghai, China
(2014)
1873 1 ~ 6y 23.8 m Perimembranous
VSD
343 (18.3%) Age diamete, Diffuse
shunt flow, aneurysmal tissue
Erol [26] Istanbul, Turkey
(2014)






425 1d ~ 6 m 5y Perimembranous313 (73.65%) muscular 53 (12.47%)
subarterial 39 (9.18%) mixed-type 20 (4.70%).
93 (21.8%) size, location, Qp/Qs,
membranous septal aneurysm










immunity to fight against infection. In this case, the
growth and development of children with higher birth
weight were less susceptible to be affected by infections.
Further studies on fetal anthropometry and haemo-
dynamics are necessary to provide insight into the rela-
tionship between cardiovascular malformations and low
birth weight. In addition, reports of SC rates in utero are
highly variable (3–46.1%), with average defects measur-
ing 1.5–2 mm in size [16, 20, 26, 28]. In the present
research, this compared with 19.1% SC rate in utero.
VSDs can increase the risk of aneuploidy of the af-
fected fetus and fetal karyotyping should be offered.
Since not all cases in our study received serum screen-
ing, control for this possibility with regards to iVSD
closure has been reported by Lee et al. [46], who found
that presence of an i-VSD before 24 weeks does increase
the risk of fetal aneuploidy. Extensive examination for
extracardiac anomalies should also be performed. Fur-
thermore, studies have demonstrated gender-based dif-
ferences in fetal cardiac diseases [47], and the SC rate of
male patients was higher than female patients in the
current investigation. However, the causes of gender-
based differences in cardiac disease are still not com-
pletely clear and require further investigation.
There were a number of limitations in the present study.
Only 76.7% of patients agreed to echocardiographic reex-
amination, which may have affected the SC rates. In
addition, the subjects included in the evaluation were
young children, and SC rates may increase with advancing
age. Due to these limitations, the available evidence allows
for crude estimates and only in children aged 2 years and
under. Therefore, assessment of long-term prognosis, es-
pecially in children beyond this age, is imperative.
Conclusion
In summary, birth weight and prenatal echocardio-
graphic measurement of size and location of VSD en-
ables the estimation of SC probability in individual
patients. These data would be particularly informative
for patients whose defect diameter indicates a high SC
probability. Information from this study can be used in
counseling of patients’ families by helping them prepare
for the possible outcome of their child’s disease.
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